Great Britain faces food, fuel and medicine shortages in no-deal Brexit, official leaked papers say

19 August 2019 - Britain will face shortages of fuel, food and medicine if it leaves the European Union without ...

Read more →

Advanced ovarian cancer drug gets initial 'no' for NHS in England

15 August 2019 - A targeted drug with potential to slow the progress of ovarian cancer has been rejected for ...

Read more →

Government to set up ‘express freight service’ for medicinal products in event of no-deal Brexit

15 August 2019 - Additional preparation to ensure continuity of supplies. ...

Read more →

Drug company Aspen may pay NHS £8 million after investigation alleges illegal deal to hike drug price

14 August 2019 - The drug company Aspen may have to pay the NHS £8 million (€8.7 million ; $9.7 ...

Read more →

Drug maker 'will make $21 billion from treating cystic fibrosis'

12 August 2019 - Vertex is accused of raking in vast profits while making Orkambi unaffordable to NHS. ...

Read more →

Is rate of return pricing a useful approach when value based pricing is not appropriate?

12 August 2019 - The pricing of new health technologies, such as drugs or devices, involves deciding how the economic ...

Read more →

Watchdog declines to back NHS cannabis treatment for epilepsy

8 August 2019 - NICE draft guidance and NHS England review highlight need for more research on cannabis-based medicinal products.
...

Read more →

NICE draft guidance and NHS England review highlight need for more research on cannabis-based medicinal products

8 August 2019 - The fast-tracked guidance follows the re-classification of these products last year to allow specialist doctors to ...

Read more →

New lung cancer treatment option approved by NICE

8 August 2019 - Another new life-extending treatment for some people with lung cancer is to be made available on the ...

Read more →

NICE recommends additional treatment option for people with early breast cancer

7 August 2019 - NICE has today published draft guidance recommending neratinib as an additional treatment for some people with early ...

Read more →

NICE expands draft recommendation for Lokelma

31 July 2019 - AstraZeneca has announced that the NICE has issued a positive Final Appraisal Document for Lokelma (sodium ...

Read more →

NICE backs Bayer’s Xarelto in new stroke and heart attack prevention use

1 August 2019 - Bayer’s Xarelto (rivaroxaban) can be funded by the NHS to prevent strokes and heart attacks in ...

Read more →

Scientific development of HTA—a proposal by the Health Technology Assessment International Scientific Development and Capacity Building Committee

29 July 2019 - This paper is a report from the Scientific Development and Capacity Building Committee of Health Technology ...

Read more →

Patient preferences studies: how NICE aims to make use of them

2 July 2019 - Dr Jacoline Bouvy, Senior Scientific Adviser, talks about a growing area of interest for the Scientific ...

Read more →

Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art

28 July 2019 - Multi-criteria decision analysis concepts, models and tools have been used increasingly in health technology assessment, with several ...

Read more →